Company intelligence / Profile preview
OmniSpirant
Clonmel, County Tipperary, Ireland
- Ownership
- Private
- Development stage
- Other
01
Overview
OmniSpirant has demonstrated promising results in preclinical disease models for CF and is conducting functional gene transfer studies and safety studies. The technology has shown mucus diffusion and tropism for cell entry and gene transfer in human lung cell models and successful aerosolization in small animal studies with in vivo gene transfer.
- Therapeutic areas
- CardiovascularOncologyPulmonologyRare Diseases
- Modalities
- Gene therapyExosome-based therapyRNA therapy
- Industry
- Biotech
02
Drug pipeline
6 assets5 more assets in the full pipeline.
Request access →03
Partnerships
Aerogen LimitedQueen's University BelfastUniversity of Galway
Beyond the preview
Go deeper on OmniSpirant.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on OmniSpirant.